dQ&A’s program to assess the impact of the COVID-19 crisis on the United States diabetes community has just wrapped up another survey wave. Data representative of the diabetes population in the United States demonstrates that booster rates are significantly higher for people with diabetes…
The FDA decided in a 10:7 vote…
We recently asked members of the dQ&A US Patient Panel about stigma in diabetes…
Results released by dQ&A and the…
While people with diabetes have been prioritized for vaccine eligibility…
There is a wide variation in quality…
Being diagnosed with diabetes can be a life-changing experience. To better understand the diagnosis experience, we reached out…
Respondents in the lower-income bracket are more likely…
dQ&A and the ADA presented data to the Congressional Diabetes Caucus on COVID-19’s impact…
In Part 1 of our exclusive CGM series, we covered the ‘tidal wave’ of CGM in diabetes. In Part 2, we are diving…
